Evidence map›Paper›PMID 25763902›Full record

SynthesisPLoS genetics2015

Genome-wide association study and meta-analysis identify ISL1 as genome-wide significant susceptibility gene for bladder exstrophy.

Markus Draaken, Michael Knapp, Tracie Pennimpede, Johanna M Schmidt, Anne-Karolin Ebert, Wolfgang Rösch, Raimund Stein, Boris Utsch, Karin Hirsch, Thomas M Boemers and 11 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Evaluation of theHuman genome variation · 2018
    Article
  19. Article
  20. Role of the LF-SINE-Derived DistalJournal of pediatric genetics · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 3 countries.

Markus DraakenInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Michael KnappInstitute of Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn, Germany.
Tracie PennimpedeDepartment of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Johanna M SchmidtInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Anne-Karolin EbertDepartment of Urology and Pediatric Urology, University Hospital of Ulm, Germany.
Wolfgang RöschDepartment of Pediatric Urology, St. Hedwig Hospital Barmherzige Brüder, Regensburg, Germany.
Raimund SteinDepartment of Urology, Division of Pediatric Urology, University of Mainz, Mainz, Germany.
Boris UtschDepartment of General Pediatrics and Neonatology, Justus Liebig University, Giessen, Germany.
Karin HirschDepartment of Urology, Division of Paediatric Urology, University of Erlangen-Nürnberg, Erlangen, Germany.
Thomas M BoemersDepartment of Pediatric Surgery and Pediatric Urology, Children's Hospital of Cologne, Cologne, Germany.
Elisabeth MangoldInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Stefanie HeilmannInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Kerstin U LudwigInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Ekkehart JenetzkyDepartment of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Johannes-Gutenberg University, Mainz, Germany.
Nadine ZwinkDepartment of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Susanne MoebusInstitute of Medical Informatics, Biometry, and Epidemiology, University Hospital of Essen, University Duisburg-Essen, Essen, Germany.
Bernhard G HerrmannDepartment of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Manuel MattheisenDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Biomedicine, Aarhus University, Aarhus, Denmark; Department of Genomic Mathematics, University of Bonn, Bonn, Germany.
Markus M NöthenInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Michael LudwigDepartment of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
Heiko ReutterInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Neonatology, Children's Hospital, University of Bonn, Bonn, Germany.
University of Bonn · DEJohannes Gutenberg University Mainz · DEMax Planck Institute for Molecular Genetics · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGerman Cancer Research Center · DEHarvard University · USKrankenhaus Barmherzige Brüder · DELife & Brain (Germany) · DEUniversity Hospital Cologne · DEUniversity Hospital Ulm · DEUniversity of Duisburg-Essen · DEUniversity of Giessen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bladder exstrophy-epispadias complex (BEEC) represents the severe end of the uro-rectal malformation spectrum, and is thought to result from aberrant embryonic morphogenesis of the cloacal membrane and the urorectal septum. The most common form of BEEC is isolated classic bladder exstrophy (CBE). To identify susceptibility loci for CBE, we performed a genome-wide association study (GWAS) of 110 CBE patients and 1,177 controls of European origin. Here, an association was found with a region of approximately 220kb on chromosome 5q11.1. This region harbors the ISL1 (ISL LIM homeobox 1) gene. Multiple markers in this region showed evidence for association with CBE, including 84 markers with genome-wide significance. We then performed a meta-analysis using data from a previous GWAS by our group of 98 CBE patients and 526 controls of European origin. This meta-analysis also implicated the 5q11.1 locus in CBE risk. A total of 138 markers at this locus reached genome-wide significance in the meta-analysis, and the most significant marker (rs9291768) achieved a P value of 2.13 × 10-12. No other locus in the meta-analysis achieved genome-wide significance. We then performed murine expression analyses to follow up this finding. Here, Isl1 expression was detected in the genital region within the critical time frame for human CBE development. Genital regions with Isl1 expression included the peri-cloacal mesenchyme and the urorectal septum. The present study identified the first genome-wide significant locus for CBE at chromosomal region 5q11.1, and provides strong evidence for the hypothesis that ISL1 is the responsible candidate gene in this region.

Indexed as

Genome-Wide Association StudyAnimalsBladder ExstrophyCase-Control StudiesHumansLIM-Homeodomain ProteinsMiceTranscription Factorsinsulin gene enhancer binding protein Isl-1LIM-Homeodomain ProteinsTranscription Factors

Identifiers

PMID25763902
PMCPMC4357422
OpenAlexW2040673960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.